丹麦科学家创造了一种有希望的新抗毒血清, 对18种主要非洲蛇种中的17种有效, 但它还没有对人类进行测试, 需要更多研究。 Danish scientists created a promising new antivenom effective against 17 of 18 major African snake species, but it hasn't been tested in humans and needs more research.

丹麦研究人员开发了一种新的基于纳米体的抗血清,对包括眼镜蛇和曼巴斯在内的18种主要非洲蛇种中的17种有效,利用工程抗体碎片进行持续、可扩展的生产。 Danish researchers have developed a new nanobody-based antivenom effective against 17 of 18 major African snake species, including cobras and mambas, using engineered antibody fragments for consistent, scalable production. 与传统动物衍生的抗毒血清不同,它表明实验室试验的安全性有所提高,副作用减少,并更好地防止组织损伤。 Unlike traditional animal-derived antivenoms, it shows improved safety, reduced side effects, and better protection against tissue damage in lab tests. 然而,它尚未在人类中进行测试,在毒液接触后被施用后效果较差,而且只是部分中和了某些物种的毒液,需要在广泛使用之前进行进一步研究和临床试验。 However, it has not yet been tested in humans, is less effective when given after venom exposure, and only partially neutralizes some species' venom, requiring further research and clinical trials before widespread use.